ATE135220T1 - Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose - Google Patents
Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporoseInfo
- Publication number
- ATE135220T1 ATE135220T1 AT93303249T AT93303249T ATE135220T1 AT E135220 T1 ATE135220 T1 AT E135220T1 AT 93303249 T AT93303249 T AT 93303249T AT 93303249 T AT93303249 T AT 93303249T AT E135220 T1 ATE135220 T1 AT E135220T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydroxy
- alpha
- osteoporosis
- dehydrovitamin
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87337492A | 1992-04-24 | 1992-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE135220T1 true ATE135220T1 (de) | 1996-03-15 |
Family
ID=25361517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93303249T ATE135220T1 (de) | 1992-04-24 | 1993-04-26 | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose |
Country Status (10)
Country | Link |
---|---|
US (1) | US5395830A (de) |
EP (1) | EP0567352B1 (de) |
JP (1) | JP2769960B2 (de) |
KR (1) | KR940005275A (de) |
AT (1) | ATE135220T1 (de) |
AU (1) | AU666529B2 (de) |
CA (1) | CA2094424C (de) |
DE (1) | DE69301750T2 (de) |
IL (1) | IL105475A (de) |
NZ (1) | NZ247406A (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US5661140A (en) * | 1994-11-21 | 1997-08-26 | Wisconsin Alumni Research Foundation | 18-nor-vitamin D compounds |
US5716946A (en) * | 1996-02-13 | 1998-02-10 | Wisconsin Alumni Research Foundation | Multiple sclerosis treatment |
KR100474517B1 (ko) * | 1997-10-27 | 2005-07-21 | 삼성전자주식회사 | 엘씨디패널절단장치 |
US6479474B2 (en) | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
WO2001022934A2 (en) * | 1999-09-24 | 2001-04-05 | Yng Wong Quing Non | Delivery of small doses of ingestible treatments |
US20060135491A1 (en) * | 2004-12-06 | 2006-06-22 | Roger Bouillon | Vitamin D3 analog useful for the treatment of osteoporosis |
ES2628503T3 (es) * | 2006-03-10 | 2017-08-03 | Dsm Ip Assets B.V. | Uso novedoso de composiciones nutracéuticas en pienso para animales |
CN102341110B (zh) | 2009-01-27 | 2017-04-12 | 博格有限责任公司 | 用于减轻与化疗有关的副作用的维生素d3及其类似物 |
CN102655869B (zh) | 2009-08-14 | 2016-08-10 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
JP6608810B2 (ja) | 2013-05-29 | 2019-11-20 | バーグ エルエルシー | ビタミンdを使用する化学療法誘発性脱毛症の予防又は軽減 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3833622A (en) * | 1969-03-17 | 1974-09-03 | Upjohn Co | Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds |
US3901928A (en) * | 1973-01-10 | 1975-08-26 | Robert Henry Hesse | 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds |
US4260549A (en) * | 1979-05-21 | 1981-04-07 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4267117A (en) * | 1978-06-19 | 1981-05-12 | The Upjohn Company | Compounds and process |
US4255596A (en) * | 1980-02-25 | 1981-03-10 | Gulf Research & Development Company | Preparation of ethylene glycol from ethylene |
JPS6089422A (ja) * | 1983-10-24 | 1985-05-20 | Kureha Chem Ind Co Ltd | 抗骨粗鬆症剤 |
US4719204A (en) * | 1984-03-05 | 1988-01-12 | Wisconsin Alumni Research Foundation | Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs |
US4588716A (en) * | 1984-05-04 | 1986-05-13 | Wisconsin Alumni Research Foundation | Method for treating metabolic bone disease in mammals |
US4588528A (en) * | 1984-05-31 | 1986-05-13 | Wisconsin Alumni Research Foundation | 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same |
US4822609A (en) * | 1984-12-21 | 1989-04-18 | The Procter & Gamble Company | Treatment of osteoporosis |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
US5001118A (en) * | 1986-12-29 | 1991-03-19 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for preventing senescence and increasing bone mass |
US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
US5053401A (en) * | 1989-02-28 | 1991-10-01 | Chugai Seiyaku Kabushiki Kaisha | Osteogenesis promotion with use of vitamin d derivatives |
-
1993
- 1993-04-13 AU AU36891/93A patent/AU666529B2/en not_active Ceased
- 1993-04-15 NZ NZ247406A patent/NZ247406A/xx unknown
- 1993-04-20 CA CA002094424A patent/CA2094424C/en not_active Expired - Fee Related
- 1993-04-21 IL IL105475A patent/IL105475A/xx not_active IP Right Cessation
- 1993-04-23 KR KR1019930006847A patent/KR940005275A/ko not_active Application Discontinuation
- 1993-04-23 JP JP5119276A patent/JP2769960B2/ja not_active Expired - Lifetime
- 1993-04-26 AT AT93303249T patent/ATE135220T1/de not_active IP Right Cessation
- 1993-04-26 EP EP93303249A patent/EP0567352B1/de not_active Expired - Lifetime
- 1993-04-26 DE DE69301750T patent/DE69301750T2/de not_active Expired - Fee Related
-
1994
- 1994-01-12 US US08/180,105 patent/US5395830A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3689193A (en) | 1993-10-28 |
EP0567352A1 (de) | 1993-10-27 |
CA2094424C (en) | 2001-01-02 |
US5395830A (en) | 1995-03-07 |
CA2094424A1 (en) | 1993-10-25 |
DE69301750D1 (de) | 1996-04-18 |
IL105475A0 (en) | 1993-08-18 |
JP2769960B2 (ja) | 1998-06-25 |
NZ247406A (en) | 1999-05-28 |
JPH0624992A (ja) | 1994-02-01 |
KR940005275A (ko) | 1994-03-21 |
DE69301750T2 (de) | 1996-07-25 |
AU666529B2 (en) | 1996-02-15 |
EP0567352B1 (de) | 1996-03-13 |
IL105475A (en) | 1997-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69435330D1 (de) | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen | |
ATE204704T1 (de) | Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten | |
ATE359074T1 (de) | Raloxifene in der behandlung von postmeopausal osteoporose | |
ATE141505T1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE3585607D1 (de) | Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet. | |
DE3785740D1 (de) | Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie. | |
ATE135220T1 (de) | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose | |
ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
WO1998025573A3 (en) | The use of celastrol to treat alzheimer's disease | |
DE69431199D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen | |
DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
DE69432626D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen | |
DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
DE3768150D1 (de) | Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie. | |
DE3675115D1 (de) | Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star. | |
DE3686097D1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
DE68916777D1 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
DE69433687D1 (de) | Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz | |
DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
ATE147267T1 (de) | Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis | |
DE3777709D1 (de) | Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis. | |
PT76582B (de) | 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel | |
DE69009989D1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |